Start for free
Start for free
Primer Capital logo

Primer Capital

Europe, Moscow City, Russian Federation, Moscow

Description

Primer Capital is a fund investing in companies engaged in development of biotech and medical products for various pharmaceutical sectors.

Investor Profile

Primer Capital has made 14 investments, with 0 in the past 12 months and 36% as lead.

Stage Focus

  • Series A (29%)
  • Seed (29%)
  • Convertible Note (14%)
  • Series Unknown (14%)
  • Series B (7%)
  • Pre Seed (7%)

Country Focus

  • Russian Federation (43%)
  • United States (29%)
  • Mexico (7%)
  • France (7%)
  • Israel (7%)
  • China (7%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Software
  • Biopharma
  • Medical Device
  • Artificial Intelligence (Ai)
  • Therapeutics
  • Finance
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Primer Capital frequently co-invest with?

TM
Tashir Medica
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
Two Sigma Ventures
Two Sigma Ventures
North America, New York, United States, New York
Co-Investments: 1
Gaingels
Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 1
Trajectory Ventures
Trajectory Ventures
North America, New York, United States, New York
Co-Investments: 1
RBV Capital
RBV Capital
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Homebrew
Homebrew
North America, California, United States, San Francisco
Co-Investments: 1
Unicorn Capital Partners
Unicorn Capital Partners
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
Karman Ventures (fka Moving Capital)
Karman Ventures (fka Moving Capital)
North America, California, United States, Santa Monica
Co-Investments: 1
Crossbeam Venture Partners
Crossbeam Venture Partners
North America, New York, United States, New York
Co-Investments: 1
Susa Ventures
Susa Ventures
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Primer Capital often collaborate with?

AP
Anthony Pompliano
North America, California, United States, San Francisco
Shared Deals: 1
GR
Gokul Rajaram
North America, California, United States, San Francisco
Shared Deals: 1
RP
Ron Pragides
North America, California, United States, San Francisco
Shared Deals: 1
EC
Emilie Choi
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Primer Capital?

Nelo

Mexico City, Distrito Federal, Mexico

Nelo increases the buying power for consumers in LatAm. Backed by Two Sigma Ventures, Homebrew, Susa Ventures, and more.

FinanceFinancial ServicesFinTechInformation TechnologyMobile AppsMobile Payments
Series AOct 12, 2021
Amount Raised: $20,000,000
MatriSys Bioscience

La Jolla, California, United States

MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
Convertible NoteMar 11, 2021
Amount Raised: $3,000,000
Botkin.AI

Moscow, Moscow City, Russian Federation

Botkin.AI is a medtech startup that is developing an AI-based radiology platform.

Artificial Intelligence (AI)Health CareSoftware
Series BDec 23, 2020
Amount Raised: $2,131,770
Athira Pharma

Seattle, Washington, United States

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

BiotechnologyPharmaceuticalTherapeutics
Convertible NoteSep 4, 2020
MatriSys Bioscience

La Jolla, California, United States

MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical
SeedOct 8, 2018
Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Series AJan 4, 2018
Amount Raised: $2,051,332
Gemopharm LLC

Moscow, Moscow City, Russian Federation

Gemopharm is an innovative biotech company developing a humanized monoclonal antibody platform to treat B-cell malignancies.

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical
Series UnknownNov 24, 2017
MT Medicals

Hefei, Anhui, China

MT Medicals developed a highly specific inhibitor of cytochrome P450 enzymes that demonstrates high conservation.

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical
Series UnknownOct 1, 2017
Bendit

Ganot, Tel Aviv, Israel

Bendit is a medical company that develops and manufactures innovative catheters based on a unique bending technology.

Health CareManufacturingMedicalMedical Device
Series ASep 3, 2017
Amount Raised: $3,550,000
Botkin.AI

Moscow, Moscow City, Russian Federation

Botkin.AI is a medtech startup that is developing an AI-based radiology platform.

Artificial Intelligence (AI)Health CareSoftware
SeedAug 2, 2017
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator